§ Funding Round
Elixiron Immunotherapeutics raised $27M Series A Plus venture round, led by pangu capital.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
CDIB Capital Group | — | — |
Daiwa Corporate Investment | — | — |
| Organization | — | |
Hong Tai Electric Industrial | — | — |
Mega International Commercial Bank | — | — |
pangu capitalLEAD | Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$40.8M
Top Valuation
-
Elixiron Immunotherapeutics raised $27M in a Series A Plus round.
The round was announced on 08/23/21.
The round was led by pangu capital.
